A network meta-analysis of the efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors for the treatment of influenza in otherwise healthy patients.

CONCLUSIONS: The NMA suggests that baloxavir demonstrated better or similar efficacy results compared to other antivirals with a comparable safety profile. Baloxavir led to a significant decrease in viral titer versus zanamivir, oseltamivir and peramivir and decreased viral shedding versus zanamivir and oseltamivir. PMID: 30810054 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30810054?dopt=Abstract

Source: Current Medical Research and Opinion - March 1, 2019 Category: Research Tags: Curr Med Res Opin Source Type: research